INTERNATIONAL EXPERTS BACK NEW PROSTATE CANCER SCREENING METHOD

An international panel of experts has endorsed a new approach to prostate cancer screening based on MRI scanning, adding pressure on health authorities to reconsider a recent rejection of the proposal. The method was shown to reduce the need for invasive biopsies by half whilst accelerating diagnoses. The endorsement comes one week after NHS health chiefs declined to approve the screening proposal. Experts are now urging officials to reverse that decision in light of the findings.

The MRI-based approach differs from conventional prostate cancer screening by identifying candidates for biopsy more precisely, reducing unnecessary procedures. The reduction in invasive biopsies represents a significant change in how the condition could be detected and managed. Speeding up diagnoses is a stated benefit of the method, which could affect how quickly patients receive confirmed results and begin treatment pathways. The international backing adds weight to calls for a formal reassessment of the NHS position.

The NHS has not yet indicated whether it will revisit its decision following the international expert endorsement. Prostate cancer is one of the most commonly diagnosed cancers in men in the United Kingdom, making any change to national screening policy potentially far-reaching. Advocates of the MRI approach argue the reduction in biopsies would also ease pressure on NHS resources. The next step, as stated by those urging a rethink, is for health officials to formally reconsider the proposal.